Recently, the 2022 Shanghai Jing'an Park "Zhangjiang Star" Enterprise Cultivation Work Exchange Meeting was successfully held. The meeting introduced the "Zhangjiang Star" enterprise cultivation work and awarded plaques to the 2022 "Zhangjiang Star" enterprises. Shanghai UnionClin Co., Ltd. was recognized as a2022 "Zhangjiang Star" Potential Enterprise. 

Since its founding in 2017, UnionClin has continuously built an efficient clinical research network and professional service system, focusing on oncology, infectious diseases, and autoimmunity, committed to providing integrated professional services throughout the entire process of new drug clinical studies. The founding team has full-chain operational experience in new drugs from early R&D to commercialization, can start from clinical needs, stand in the sponsor's perspective,  plan and integrate resources, and help clients succeed. Currently, the team has nearly 700 members, distributed in over 25 cities nationwide, and has provided services for more than 150 new drug clinical studies.

Related Exciting Recommendations